oral vinorelbine

You have access
Combined chemo-endocrine therapy as a potential new option for HR+/HER2− advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine
Xue Wang, Jian Yue, Yikun Kang, Zhong Dai, Jie Ju, Jiayu Wang, Pin Zhang, Fei Ma, Binghe Xu and Peng Yuan

Cancer Biology & Medicine April 2023, 20 (4) 287-296; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0702
You have access
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A. Osman, Gustavo N. Marta, Gianluca Franceschini and Armando Orlandi

Cancer Biology & Medicine August 2021, 18 (3) 875-887; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0418

Main menu